This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft
Pot Stocks Take Markets Higher; Plus Beats for Cisco, Twitter, Lyft
by Mark Vickery
With Tilray (TLRY) +44% and Canopy (CGC) +12% on the day, the Nasdaq and Russell 2000 managed to climb to fresh all-time highs Tuesday.
Cannabis ETFs Spike on Jazz-GW Pharma Deal
by Sweta Killa
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Cannabis ETF Tops in January: 5 Stocks That Led the Way
by Sweta Killa
Inside the top performing stocks in the top ETF of January.
Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day
3 Marijuana Stocks to Play the Green Rush in 2021
by Tirthankar Chakraborty
Marijuana stocks are set to be the rage on Wall Street in hopes of legalization in and around the United States, which calls for keeping an eye on the likes of Tilray (TLRY) and Square (SQ).
Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TLRY) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray
Here're the 5 Top Stock Trades for 2021
by Tirthankar Chakraborty
We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).
Tilray (KL) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
Tilray (KL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant
by Sweta Killa
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Company News for Dec 17, 2020
by Zacks Equity Research
Companies In The News Are: GOOGL, LUV, TLRY, APHA, GLPG, GILD.
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Is a Disappointment in Store for Tilray's (TLRY) Q3 Earnings?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports third-quarter 2020 results.
Implied Volatility Surging for Tilray (TLRY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Tilray, Inc. (TLRY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 3.70% and -8.87%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Tilray (TLRY) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports second-quarter 2020 results.
Will Tilray, Inc. (TLRY) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $7.38 in the latest trading session, marking a -1.99% move from the prior day.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Cannabis ETF Tops in May: 5 Stocks That Led The Way
by Sweta Killa
Inside the best performing stocks in the top cannabis ETF of May.